Published in Am J Gastroenterol on March 15, 2011
Fecal Transplantation for Chronic Pouchitis - A Pilot Study | NCT03538366
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol (2012) 2.03
Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut (2015) 1.80
Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol (2013) 1.53
Biodiversity and functional genomics in the human microbiome. Trends Genet (2012) 1.52
Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci (2014) 1.41
The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes (2012) 1.32
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease. Cell Host Microbe (2015) 1.29
Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A (2015) 1.25
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis (2014) 1.13
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One (2011) 1.11
Impact of the gut microbiome on mucosal inflammation. Trends Immunol (2013) 1.03
Treatment of IBD: where we are and where we are going. Am J Gastroenterol (2014) 1.02
The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2014) 1.01
Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol (2015) 1.00
Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci (2012) 0.99
Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep (2012) 0.97
big bang gene modulates gut immune tolerance in Drosophila. Proc Natl Acad Sci U S A (2013) 0.95
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One (2013) 0.93
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
Use of the tumor necrosis factor-blockers for Crohn's disease. World J Gastroenterol (2012) 0.91
Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg (2012) 0.91
Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS One (2015) 0.91
The intestinal microbiota: its role in health and disease. Eur J Pediatr (2015) 0.88
The gut microbiome: scourge, sentinel or spectator? J Oral Microbiol (2012) 0.88
Identifying strains that contribute to complex diseases through the study of microbial inheritance. Proc Natl Acad Sci U S A (2015) 0.88
Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens (2014) 0.88
Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study. PLoS One (2013) 0.87
Interactions between the intestinal microbiota and innate lymphoid cells. Gut Microbes (2013) 0.86
Use of antibiotics in the treatment of Crohn's disease. World J Gastroenterol (2013) 0.86
Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice. Toxicol Sci (2012) 0.85
Bugging inflammation: role of the gut microbiota. Clin Transl Immunology (2016) 0.84
Therapeutic drug monitoring in patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.84
The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol (2016) 0.84
Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol (2016) 0.82
How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol (2016) 0.81
Management of Crohn's disease. Arch Dis Child (2015) 0.81
Pediatric ulcerative colitis: current treatment approaches including role of infliximab. Biologics (2012) 0.81
Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int (2014) 0.81
Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatric Infect Dis Soc (2012) 0.81
Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology. Indian J Dermatol (2016) 0.80
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis (2013) 0.80
Dysbiosis and the immune system. Nat Rev Immunol (2017) 0.79
Inflammatory bowel disease. Middle East J Dig Dis (2012) 0.79
A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation. FEBS J (2016) 0.79
Dietary ganglioside reduces proinflammatory signaling in the intestine. J Nutr Metab (2012) 0.79
Infectious etiopathogenesis of Crohn's disease. World J Gastroenterol (2014) 0.79
Current therapy of pediatric Crohn's disease. World J Gastrointest Pathophysiol (2015) 0.78
Increased frequency of intestinal CD4+ T cells reactive with mycobacteria in patients with Crohn's disease. Scand J Gastroenterol (2013) 0.78
Molecular analysis of sarcoidosis lymph nodes for microorganisms: a case-control study with clinical correlates. BMJ Open (2013) 0.78
The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measures. Int J Rheumatol (2013) 0.78
Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation. Inflamm Bowel Dis (2014) 0.78
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
Colonic crohn disease. Clin Colon Rectal Surg (2013) 0.78
Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol (2015) 0.78
Prospects for therapeutic tolerance in humans. Curr Opin Rheumatol (2014) 0.78
Small-molecule modulators of PXR and CAR. Biochim Biophys Acta (2016) 0.78
Practical medical management of Crohn's disease. ISRN Gastroenterol (2013) 0.77
Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol (2017) 0.77
Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients. Clin Transl Gastroenterol (2016) 0.76
Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol (2016) 0.76
Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.76
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 0.76
Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria. Front Immunol (2015) 0.75
Autoimmunity and the gut. Autoimmune Dis (2014) 0.75
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis. Aliment Pharmacol Ther (2015) 0.75
Septic knee arthritis in Crohn's disease biological therapy-free patient. Case report. J Med Life (2015) 0.75
A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases. Front Immunol (2017) 0.75
Long-term antibiotic therapy in late onset pouch-urethral fistula after ileoanal anastomosis for ulcerative colitis may be effective and well tolerated. BMJ Case Rep (2013) 0.75
Preventive health measures in inflammatory bowel disease. World J Gastroenterol (2016) 0.75
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep (2016) 0.75
Mycobacterium paratuberculosis as a cause of Crohn's disease. Expert Rev Gastroenterol Hepatol (2015) 0.75
Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells? Sci Rep (2016) 0.75
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw (2017) 0.75
The genetics and pathogenesis of inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.75
Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol (2016) 0.75
Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial. BMC Vet Res (2016) 0.75
NOD2 prevents emergence of disease-predisposing microbiota. Gut Microbes (2013) 0.75
Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. World J Gastroenterol (2014) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75
Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol (2016) 0.75
An expanding stage for commensal microbes in host immune regulation. Cell Mol Immunol (2017) 0.75
Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease. Inflamm Bowel Dis (2016) 0.75
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D. Inflamm Bowel Dis (2015) 0.75
Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new? World J Gastrointest Surg (2016) 0.75
Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y) (2013) 0.75
Fistulizing Crohn's Disease. Clin Transl Gastroenterol (2017) 0.75
Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study. Int J Colorectal Dis (2016) 0.75
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77
Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med (2003) 5.15
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol (2012) 4.78
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28
Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol (2007) 4.14
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2011) 3.97
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Functional Dyspepsia. N Engl J Med (2015) 3.66
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med (2014) 2.98
Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol (2013) 2.97
Gastro-oesophageal reflux disease. Lancet (2006) 2.96
Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol (2003) 2.96
A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med (2006) 2.94
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA (2008) 2.89
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol (2003) 2.83
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology (2004) 2.59
Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol (2005) 2.56
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol (2008) 2.52
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev (2010) 2.47
Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2012) 2.46
Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology (2006) 2.46
American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology (2005) 2.39
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology (2002) 2.35
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Minimizing postcolonoscopy abdominal pain by using CO(2) insufflation: a prospective, randomized, double blind, controlled trial evaluating a new commercially available CO(2) delivery system. Gastrointest Endosc (2002) 2.24
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol (2006) 2.21
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut (2010) 2.21
Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine. Am J Gastroenterol (2003) 2.20
Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology (2009) 2.19
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol (2011) 2.19
Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies. Am J Gastroenterol (2013) 2.18
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology (2013) 2.13
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.09
Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology (2005) 2.07
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol (2004) 2.05
Risks of proton-pump inhibitors: what every doctor should know. Med J Aust (2009) 2.03
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med (2013) 2.01
Does Helicobacter pylori really cause duodenal ulcers? Yes. BMJ (2009) 2.01
Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol (2007) 2.00
Prevalence of faecal incontinence and associated risk factors; an underdiagnosed problem in the Australian community? Med J Aust (2002) 2.00
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology (2003) 1.95
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology (2002) 1.94
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab. Am J Gastroenterol (2005) 1.93
Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut (2006) 1.92
The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol (2005) 1.90
Initial management of dyspepsia in primary care: an evidence-based approach. Br J Gen Pract (2013) 1.90
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology (2008) 1.89
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol (2011) 1.88
Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol (2009) 1.88
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86
Systematic review on the management of chronic constipation in North America. Am J Gastroenterol (2005) 1.85
EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointest Endosc (2008) 1.85
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol (2005) 1.84
Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med (2012) 1.80
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut (2011) 1.80
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology (2006) 1.78
Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol (2008) 1.78
The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology (2008) 1.77